| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7171c61e9aa2d6f03cc0a72978bc3b2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d486ecfe934e08df55533af4b31764
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96e1bced372ca18c832f733eac7bed7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66826a8839b7844496de99d24364d63b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0c1e970e78a4f28926468d3cab86391
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b3a7980089e465dd2426ca1770502e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f1d3d744d474ddefa9afa3879866c65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff78701b09f35f5125d4698f30138955 |
| publicationDate |
2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3004165-A1 |
| titleOfInvention |
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas |
| abstract |
The present invention relates to a ligand molecule that specifically binds to KTR3DL2 at the surface of KTR3DL2 expressing malignant T-cells for the treatment of lymphomas. It also relates to the in vitro use of a level of expression of KIR3DL2 is a biomarker useful for diagnosing and/or monitoring a lymphoma. |
| priorityDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |